Andrei Iagaru

Radiologist

Associate Professor of Radiology at the Stanford University Medical Center
Dr. Iagaru is an Associate Professor of Radiology - Nuclear Medicine and the Co-Chief of the Division of Nuclear Medicine and Molecular Imaging at Stanford University Medical Center. He completed medical school at Carol Davila University of Medicine, Bucharest, Romania, and an internship at Drexel University College of Medicine, Graduate Hospital, in the Department of Medicine in Philadelphia. He began his residency at the University of Southern California (USC) Keck School of Medicine, Los Angeles, in the Division of Nuclear Medicine, where he was the chief resident. Dr. Iagaru finished his residency and completed a PET/CT fellowship at Stanford University's School of Medicine in the Division of Nuclear Medicine. His research interests include PET/MRI and PET/CT for early cancer detection; clinical translation of novel PET radiopharmaceuticals; peptide-based diagnostic imaging and therapy; and radioimmunotherapy.

Over the past seven years since joining the faculty at Stanford, Dr. Iagaru has received several awards including the Society of Nuclear Medicine (SNM) 2009 Image of the Year Award; American College of Nuclear Medicine (ACNM) Mid-Winter Conference 2010 Best Essay Award; 2009 Western Regional SNM Scientist Award; 2011 SNM Nuclear Oncology Council Young Investigator Award; and a Stanford Cancer Center 2009 Developmental Cancer Research Award in Translational Science. Dr. Iagaru presented more than 90 abstracts at national and international meetings and published more than 60 papers in peer-reviewed journals, as well as 7 book chapters.

Professional Education

Residency: Stanford University Medical Center (2006) CA

Fellowship: Stanford University Medical Center (2007) CA

Board Certification: Nuclear Medicine, American Board of Nuclear Medicine (2006)

Residency: USC - Keck School of Medicine (2005) CA

Internship: Graduate Hospital (2004) PA

Medical Education: Carol Davila University of Medicine (2000) Romania

Honors & Awards

Fellow Award, American College of Nuclear Medicine (2013)

Nuclear Oncology Council Young Investigator Award - Second Place, Society of Nuclear Medicine and Molecular Imaging (2011)

Radiopharmaceutical Sciences Council Travel Grant, Society of Nuclear Medicine and Molecular Imaging (2011)

Young Professionals Tournament - First Place, SNMMI & Chinese Society of Nuclear Medicine Joint Meeting (2011)

Best Essay Award, American College of Nuclear Medicine (2011)

Alavi-Mandell Award, Society of Nuclear Medicine and Molecular Imaging (2010)

Best Essay Award, American College of Nuclear Medicine (2010)

Norman D. Poe Memorial Scholarship Award, Western Regional Society of Nuclear Medicine (2009)

Developmental Cancer Research Award, Stanford Cancer Center (2009)

Image of the Year, Society of Nuclear Medicine and Molecular Imaging (2009)

Alavi-Mandell Award, Society of Nuclear Medicine and Molecular Imaging (2009)

Clinician Educator of the Year Award, Stanford Radiology Residency Program (2008)

Alavi-Mandell Award, Society of Nuclear Medicine and Molecular Imaging (2008)

Best Essay Award, American College of Nuclear Physicians (2008)

Travel Grant, American College of Nuclear Physicians (2007)

Administrative Appointments

Program Director, Nuclear Medicine Residency Program (2011 - Present)

Member, Department of Radiology Education Committee (2009 - Present)

Member, Clinical Radiation Safety Committee (2009 - Present)

Member, Scientific Review Committee, Stanford Cancer Institute (2012 - Present)

Circulating Tumor Microemboli Diagnostics for Patients with Non-Small-Cell Lung Cancer
Carlsson, A., Nair, V. S., Luttgen, M. S., Keu, K. V., Horng, G., & Gambhir, S. S. (2014). Circulating Tumor Microemboli Diagnostics for Patients with Non-Small-Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 9(8), 1111-1119.

F-18-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder
Takehana, C. S., Twist, C. J., Mosci, C., Quon, A., Mittra, E., & Iagaru, A. (2014). F-18-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder. NUCLEAR MEDICINE COMMUNICATIONS, 35(3), 276-281.

The Clinical Use of PET/CT in the Evaluation of Melanoma.
Keu, K. V., & Iagaru, A. H. (2014). The Clinical Use of PET/CT in the Evaluation of Melanoma. Methods in molecular biology (Clifton, N.J.), 1102, 553-580.

Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT.
Lam, M. Geh., Goris, M. L., Iagaru, A. H., Mittra, E. S., Louie, J. D., & Sze, D. Y. (2013). Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 54(12), 2055-2061.

Root Cause Analysis of Gastroduodenal Ulceration After Yttrium-90 Radioembolization
Lam, M. Geh., Banerjee, S., Louie, J. D., Abdelmaksoud, M. Hk., Iagaru, A. H., & Sze, D. Y. (2013). Root Cause Analysis of Gastroduodenal Ulceration After Yttrium-90 Radioembolization. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 36(6), 1536-1547.

Prognostic Utility of Y-90 Radioembolization Dosimetry Based on Fusion Tc-99m-Macroaggregated Albumin-Tc-99m-Sulfur Colloid SPECT
Lam, M. Geh., Goris, M. L., Iagaru, A. H., Mittra, E. S., Louie, J. D., & Sze, D. Y. (2013). Prognostic Utility of Y-90 Radioembolization Dosimetry Based on Fusion Tc-99m-Macroaggregated Albumin-Tc-99m-Sulfur Colloid SPECT. JOURNAL OF NUCLEAR MEDICINE, 54(12), 2055-2061.

Combined 18F-fluoride and 18F-FDG PET/CT: a response based on actual data from prospective studies.
Iagaru, A., Mosci, C., Dick, D. W., Sathekge, M., Lapa, P., & Gambhir, S. S. (2013). Combined 18F-fluoride and 18F-FDG PET/CT: a response based on actual data from prospective studies. European journal of nuclear medicine and molecular imaging, 40(12), 1922-1924.

Safety of Repeated Yttrium-90 Radioembolization
Lam, M. Geh., Louie, J. D., Iagaru, A. H., Goris, M. L., & Sze, D. Y. (2013). Safety of Repeated Yttrium-90 Radioembolization. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 36(5), 1320-1328.

Imaging tumor angiogenesis: the road to clinical utility.
Iagaru, A., & Gambhir, S. S. (2013). Imaging tumor angiogenesis: the road to clinical utility. AJR. American journal of roentgenology, 201(2), W183-91.

An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer
Nair, V. S., Keu, K. V., Luttgen, M. S., Kolatkar, A., Vasanawala, M., & Kuhn, P. (2013). An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer. PLOS ONE, 8(7).

Pilot Prospective Evaluation of Tc-99m-MDP Scintigraphy, F-18 NaF PET/CT, F-18 FDG PET/CT and Whole-Body MRI for Detection of Skeletal Metastases
Iagaru, A., Young, P., Mittra, E., Dick, D. W., Herfkens, R., & Gambhir, S. S. (2013). Pilot Prospective Evaluation of Tc-99m-MDP Scintigraphy, F-18 NaF PET/CT, F-18 FDG PET/CT and Whole-Body MRI for Detection of Skeletal Metastases. CLINICAL NUCLEAR MEDICINE, 38(7), E290-E296.

Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
Iagaru, A., Young, P., Mittra, E., Dick, D. W., Herfkens, R., & Gambhir, S. S. (2013). Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases. Clinical nuclear medicine, 38(7), e290-6.

Second Sino-American Conference on Nuclear Medicine
Delbeke, D., Alessio, A., & Iagaru, A. (2013). Second Sino-American Conference on Nuclear Medicine. JOURNAL OF NUCLEAR MEDICINE, 54(4), 15N-16N.

Combined F-18-Fluoride and F-18-FDG PET/CT Scanning for Evaluation of Malignancy: Results of an International Multicenter Trial
Iagaru, A., Mittra, E., Mosci, C., Dick, D. W., Sathekge, M., & Gambhir, S. S. (2013). Combined F-18-Fluoride and F-18-FDG PET/CT Scanning for Evaluation of Malignancy: Results of an International Multicenter Trial. JOURNAL OF NUCLEAR MEDICINE, 54(2), 176-183.

An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer.
Nair, V. S., Keu, K. V., Luttgen, M. S., Kolatkar, A., Vasanawala, M., & Kuhn, P. (2013). An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer. PloS one, 8(7).

18F-FDG PET/CT Demonstration of Diffuse Lymphohistiocytic Granulomatous Vasculitis.
Kumar, M., & Iagaru, A. (2013). 18F-FDG PET/CT Demonstration of Diffuse Lymphohistiocytic Granulomatous Vasculitis. Clinical nuclear medicine.

Initial investigation of F-18-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery
Quon, A., Dodd, R., Iagaru, A., de Abreu, M. R., Hennemann, S., & Sprinz, C. (2012). Initial investigation of F-18-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 39(11), 1737-1744.

The Impact of Partial Volume Correction in the Evaluation of Solitary Pulmonary Nodules by FDG PET/CT in a Population at Intermediate Risk of Lung Cancer
Keu, K., Nair, V. S., Mittra, E., Gambhir, S. S., & Iagaru, A. (2012). The Impact of Partial Volume Correction in the Evaluation of Solitary Pulmonary Nodules by FDG PET/CT in a Population at Intermediate Risk of Lung Cancer. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 39, S455-S455.

Positron Emission Tomography of Cu-64-DOTA-Rituximab in a Transgenic Mouse Model Expressing Human CD20 for Clinical Translation to Image NHL
Natarajan, A., Gowrishankar, G., Nielsen, C. H., Wang, S., Iagaru, A., & Gambhir, S. S. (2012). Positron Emission Tomography of Cu-64-DOTA-Rituximab in a Transgenic Mouse Model Expressing Human CD20 for Clinical Translation to Image NHL. MOLECULAR IMAGING AND BIOLOGY, 14(5), 608-616.

F-18-FDG PET/CT Demonstration of a Liver Metastasis in a Patient With Papillary Thyroid Cancer
Mosci, C., McDougall, I. R., Jeffrey, R. B., & Iagaru, A. (2012). F-18-FDG PET/CT Demonstration of a Liver Metastasis in a Patient With Papillary Thyroid Cancer. CLINICAL NUCLEAR MEDICINE, 37(9), E234-E236.

Validation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer
Tang, C., Murphy, J. D., Khong, B., La, T. H., Kong, C., & Quynh-Thu Le, Q. T. (2012). Validation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(5), 1514-1520.

Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes
Chu, K. P., Murphy, J. D., La, T. H., Krakow, T. E., Iagaru, A., & Quynh-Thu Le, Q. T. (2012). Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(5), 1521-1527.

Prospective Evaluation of Tc-99m MDP Scintigraphy, F-18 NaF PET/CT, and F-18 FDG PET/CT for Detection of Skeletal Metastases
Iagaru, A., Mittra, E., Dick, D. W., & Gambhir, S. S. (2012). Prospective Evaluation of Tc-99m MDP Scintigraphy, F-18 NaF PET/CT, and F-18 FDG PET/CT for Detection of Skeletal Metastases. MOLECULAR IMAGING AND BIOLOGY, 14(2), 252-259.

Demonstration of peripheral nerve root involvement by non-Hodgkin's lymphoma on F-18-FDG PET/CT
Guo, H., Mosci, C., & Iagaru, A. (2012). Demonstration of peripheral nerve root involvement by non-Hodgkin's lymphoma on F-18-FDG PET/CT. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 39(4), 729-730.

Prospective comparison of combined F-18-FDG and F-18-NaF PET/CT vs. F-18-FDG PET/CT imaging for detection of malignancy
Lin, F. I., Rao, J. E., Mittra, E. S., Nallapareddy, K., Chengapa, A., & Iagaru, A. (2012). Prospective comparison of combined F-18-FDG and F-18-NaF PET/CT vs. F-18-FDG PET/CT imaging for detection of malignancy. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 39(2), 262-270.

Response to Intra-Arterial Oncolytic Virotherapy with the Herpes Virus NV1020 Evaluated by [F-18]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography
Sze, D. Y., Iagaru, A. H., Gambhir, S. S., de Haan, H. A., & Reid, T. R. (2012). Response to Intra-Arterial Oncolytic Virotherapy with the Herpes Virus NV1020 Evaluated by [F-18]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography. HUMAN GENE THERAPY, 23(1), 91-97.

Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity
Murphy, J. D., Chisholm, K. M., Daly, M. E., Wiegner, E. A., Truong, D., & Le, Q.-T. (2011). Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity. RADIOTHERAPY AND ONCOLOGY, 101(3), 356-361.

PET/CT Imaging of Thyroid Cancer
Mosci, C., & Iagaru, A. (2011). PET/CT Imaging of Thyroid Cancer. CLINICAL NUCLEAR MEDICINE, 36(12), E180-E185.

Pilot Pharmacokinetic and Dosimetric Studies of F-18-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging alpha(v)beta(3) Integrin Levels
Mittra, E. S., Goris, M. L., Iagaru, A. H., Kardan, A., Burton, L., & Gambhir, S. S. (2011). Pilot Pharmacokinetic and Dosimetric Studies of F-18-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging alpha(v)beta(3) Integrin Levels. RADIOLOGY, 260(1), 182-191.

FDG-PET/CT in Cancers of the Head and Neck: What is the Definition of Whole Body Scanning?
Iagaru, A., Mittra, E. S., & Gambhir, S. S. (2011). FDG-PET/CT in Cancers of the Head and Neck: What is the Definition of Whole Body Scanning?. MOLECULAR IMAGING AND BIOLOGY, 13(2), 362-367.

Thyroid Stunning: Fact or Fiction?
McDougall, I. R., & Iagaru, A. (2011). Thyroid Stunning: Fact or Fiction?. SEMINARS IN NUCLEAR MEDICINE, 41(2), 105-112.

Case 166: Metastatic Left Pulmonary Artery Sarcoma
Mittra, E. S., Iagaru, A. H., & Leung, A. N. (2011). Case 166: Metastatic Left Pulmonary Artery Sarcoma. RADIOLOGY, 258(2), 645-648.

(18)F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge.
Iagaru, A. (2011). (18)F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge. American journal of nuclear medicine and molecular imaging, 1(1), 63-64.

Current concepts and future directions in radioimmunotherapy.
Lin, F. I., & Iagaru, A. (2010). Current concepts and future directions in radioimmunotherapy. Current drug discovery technologies, 7(4), 253-262.

F-18 FDG PET/CT Demonstration of Lymphohistiocytic Meningitis
Mansouri, M. A., & Iagaru, A. (2010). F-18 FDG PET/CT Demonstration of Lymphohistiocytic Meningitis. CLINICAL NUCLEAR MEDICINE, 35(8), 633-634.

I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (ZevalinA (R)) Therapy of Low-Grade Refractory/Relapsed Non-Hodgkin Lymphoma
Iagaru, A., Mittra, E. S., Ganjoo, K., Knox, S. J., & Goris, M. L. (2010). I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (ZevalinA (R)) Therapy of Low-Grade Refractory/Relapsed Non-Hodgkin Lymphoma. MOLECULAR IMAGING AND BIOLOGY, 12(2), 198-203.

Combined F-18-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future? REPLY
Iagaru, A., Mittra, E., Goris, M. L., & Gambhir, S. S. (2010). Combined F-18-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future? REPLY. JOURNAL OF NUCLEAR MEDICINE, 51(1), 166-167.

Efficacy of F-18-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma
Mittra, E., El-Maghraby, T., Rodriguez, C. A., Quon, A., McDougall, I. R., & Iagaru, A. (2009). Efficacy of F-18-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 36(12), 1952-1959.

Efficacy of F-18-FDG PET/CT for Breast Cancer
Mittra, E., Quon, A., Gambhir, S. S., & Iagaru, A. (2009). Efficacy of F-18-FDG PET/CT for Breast Cancer. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 36, S176-S176.

Evaluation by F-18-FDG-PET of patients with anal squamous cell carcinoma
Iagaru, A., Kundu, R., Jadvar, H., & Nagle, D. (2009). Evaluation by F-18-FDG-PET of patients with anal squamous cell carcinoma. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 12(1), 26-29.

Tumor Metabolic Phenotypes on F-18 FDG PET REPLY
Iagaru, A. H., Gambhir, S. S., & Goris, M. L. (2009). Tumor Metabolic Phenotypes on F-18 FDG PET REPLY. JOURNAL OF NUCLEAR MEDICINE, 50(6), 1011-1012.

Incorporating Cone-beam CT into the Treatment Planning for Yttrium-90 Radioembolization
Louie, J. D., Kothary, N., Kuo, W. T., Hwang, G. L., Hofmann, L. V., & Sze, D. Y. (2009). Incorporating Cone-beam CT into the Treatment Planning for Yttrium-90 Radioembolization. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 20(5), 606-613.

Novel Strategy for a Cocktail F-18-Fluoride and F-18-FDG PET/CT Scan for Evaluation of Malignancy: Results of the Pilot-Phase Study
Iagaru, A., Mittra, E., Yaghoubi, S. S., Dick, D. W., Quon, A., & Gambhir, S. S. (2009). Novel Strategy for a Cocktail F-18-Fluoride and F-18-FDG PET/CT Scan for Evaluation of Malignancy: Results of the Pilot-Phase Study. JOURNAL OF NUCLEAR MEDICINE, 50(4), 501-505.

F-18-FDG PET/CT evaluation of patients with ovarian carcinoma
Iagaru, A. H., Mittra, E. S., McDougall, I. R., Quon, A., & Gambhir, S. S. (2008). F-18-FDG PET/CT evaluation of patients with ovarian carcinoma. NUCLEAR MEDICINE COMMUNICATIONS, 29(12), 1046-1051.

Y-90-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma: Observations from In-111-Ibritumomab Pretreatment Imaging
Iagaru, A., Gambhir, S. S., & Goris, M. L. (2008). Y-90-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma: Observations from In-111-Ibritumomab Pretreatment Imaging. JOURNAL OF NUCLEAR MEDICINE, 49(11), 1809-1812.

Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on Tc-99m-MDP bone scintigraphy confirmed by F-18-18 FDG PET/CT and bone marrow biopsy
Iagaru, A., & Goris, M. L. (2008). Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on Tc-99m-MDP bone scintigraphy confirmed by F-18-18 FDG PET/CT and bone marrow biopsy. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 35(9), 1746-1746.

F-18-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?
Iagaru, A., Wang, Y., Mari, C., Quon, A., Goris, M. L., & Gambhir, S. S. (2008). F-18-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 11(3), 153-156.

Perspectives of molecular imaging and radioimmunotherapy in lymphoma
Iagaru, A., Goris, M. L., & Gambhir, S. S. (2008). Perspectives of molecular imaging and radioimmunotherapy in lymphoma. RADIOLOGIC CLINICS OF NORTH AMERICA, 46(2), 243-252.

I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma
Iagaru, A., Peterson, D., Quon, A., Dutta, S., Twist, C., & Albanese, C. (2008). I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma. MOLECULAR IMAGING AND BIOLOGY, 10(1), 19-23.

F-18FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas
Iagaru, A., Masamed, R., Chawla, S. P., Menendez, L. R., Fedenko, A., & Conti, P. S. (2008). F-18FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas. CLINICAL NUCLEAR MEDICINE, 33(1), 8-13.

Molecular imaging can accelerate anti-angiogenic drug development and testing
Lagaru, A., Chen, X., & Gambhir, S. S. (2007). Molecular imaging can accelerate anti-angiogenic drug development and testing. NATURE CLINICAL PRACTICE ONCOLOGY, 4(10), 556-557.

F-18 FDG PET/CT in the management of thyroid cancer
Iagaru, A., Kalinyak, J. E., & McDougall, I. R. (2007). F-18 FDG PET/CT in the management of thyroid cancer. CLINICAL NUCLEAR MEDICINE, 32(9), 690-695.

Advances in metabolic imaging for surgical oncology
Iagaru, A., & Quon, A. (2007). Advances in metabolic imaging for surgical oncology. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 16(2), 273-?.

Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT
Iagaru, A., Masamed, R., Singer, P. A., & Conti, P. S. (2007). Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT. MOLECULAR IMAGING AND BIOLOGY, 9(2), 72-77.

Treatment of thyrotoxicosis
Iagaru, A., & McDougall, I. R. (2007). Treatment of thyrotoxicosis. JOURNAL OF NUCLEAR MEDICINE, 48(3), 379-389.

F-18 FDG PET visualization of urinary leak after nephrostomy tube removal
Iagaru, A., Gamie, S., & Segall, G. (2007). F-18 FDG PET visualization of urinary leak after nephrostomy tube removal. CLINICAL NUCLEAR MEDICINE, 32(2), 168-169.

Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation
Iagaru, A., Mari, C., & Gambhir, S. S. (2007). Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation. REVISTA ESPANOLA DE MEDICINA NUCLEAR, 26(1), 40-45.

2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma
Iagaru, A., Quon, A., Johnson, D., Gambhir, S. S., & McDougall, I. R. (2007). 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma. MOLECULAR IMAGING AND BIOLOGY, 9(1), 50-57.

F-18FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer
Iagaru, A., & McDougall, I. R. (2007). F-18FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer. CLINICAL NUCLEAR MEDICINE, 32(1), 13-15.

Breast MRI and F-18 FDG PET/CT in the management of breast cancer
Iagaru, A., Masamed, R., Keesara, S., & Conti, P. S. (2007). Breast MRI and F-18 FDG PET/CT in the management of breast cancer. ANNALS OF NUCLEAR MEDICINE, 21(1), 33-38.

F-18FDG PET/CT evaluation of osseous and soft tissue sarcomas
Iagaru, A., Quon, A., McDougall, T. R., & Gambhir, S. S. (2006). F-18FDG PET/CT evaluation of osseous and soft tissue sarcomas. CLINICAL NUCLEAR MEDICINE, 31(12), 754-760.

F-18-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas
Iagaru, A., Chawla, S., Menendez, L., & Conti, P. S. (2006). F-18-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. NUCLEAR MEDICINE COMMUNICATIONS, 27(10), 795-802.

2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer
Iagaru, A., Masamed, R., Singer, P. A., & Conti, P. S. (2006). 2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer. MOLECULAR IMAGING AND BIOLOGY, 8(5), 309-314.

Demonstration of an ectopic mediastinal parathyroid adenoma on Tc-99m sestamibi myocardial perfusion scintigraphy
Iagaru, A., Hachamovitch, R., Colletti, P. M., & Wassef, H. (2006). Demonstration of an ectopic mediastinal parathyroid adenoma on Tc-99m sestamibi myocardial perfusion scintigraphy. JOURNAL OF NUCLEAR CARDIOLOGY, 13(5), 719-721.

PET/CT follow-up in nonossifying fibroma
Iagaru, A., & Henderson, R. (2006). PET/CT follow-up in nonossifying fibroma. AMERICAN JOURNAL OF ROENTGENOLOGY, 187(3), 830-832.

F-18FDG PET imaging of urinary bladder oat cell carcinoma with widespread osseous metastases
Iagaru, A., Gamie, S., & Segall, G. (2006). F-18FDG PET imaging of urinary bladder oat cell carcinoma with widespread osseous metastases. CLINICAL NUCLEAR MEDICINE, 31(8), 476-478.

Merkel cell carcinoma: Is there a role for 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography?
Iagaru, A., Quon, A., McDougall, I. R., & Gambhir, S. S. (2006). Merkel cell carcinoma: Is there a role for 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography?. MOLECULAR IMAGING AND BIOLOGY, 8(4), 212-217.

F-18FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation
Iagaru, A., Mari, C., & Segall, G. (2006). F-18FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation. CLINICAL NUCLEAR MEDICINE, 31(5), 279-280.

Demonstration of a right inguinal hernia containing urinary bladder diverticulum on whole-body bone scan and pelvic CT
Iagaru, A., & Siegel, M. E. (2006). Demonstration of a right inguinal hernia containing urinary bladder diverticulum on whole-body bone scan and pelvic CT. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 33(2), 234-234.

Failed atrial septal defect repair versus pulmonary hypertension with right ventricular failure
Iagaru, A., Wassef, H., & Henderson, R. (2005). Failed atrial septal defect repair versus pulmonary hypertension with right ventricular failure. CLINICAL NUCLEAR MEDICINE, 30(11), 767-768.

FDG PET-CT demonstration of Sjogren's sialoadenitis
Jadvar, H., Bonyadlou, S., Iagaru, A., & Colletti, P. M. (2005). FDG PET-CT demonstration of Sjogren's sialoadenitis. CLINICAL NUCLEAR MEDICINE, 30(10), 698-699.